Package 53045-140-30

Brand: avant

Generic: benzocaine
NDC Package

Package Facts

Identity

Package NDC 53045-140-30
Digits Only 5304514030
Product NDC 53045-140
Product ID 53045-140_33eb6c31-6bd2-4c7c-b7e3-01088def8fc7
Description

32 g in 1 BOTTLE (53045-140-30)

Marketing

Marketing Status
Marketed Since 2021-01-22
Brand avant
Generic benzocaine
Sample Package No

Linked Drug Pages (1)

Avant ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["DENTAL"], "spl_id": "33eb6c31-6bd2-4c7c-b7e3-01088def8fc7", "openfda": {"nui": ["N0000185508", "N0000175629", "N0000184306", "M0000728"], "unii": ["U3RSY48JW5"], "spl_set_id": ["886d949b-8db1-499c-a277-174f8bc29f34"], "pharm_class_cs": ["Allergens [CS]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]"], "pharm_class_epc": ["Standardized Chemical Allergen [EPC]"], "manufacturer_name": ["Dharma Research, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "32 g in 1 BOTTLE (53045-140-30)", "package_ndc": "53045-140-30", "marketing_start_date": "20210122"}], "brand_name": "Avant", "product_id": "53045-140_33eb6c31-6bd2-4c7c-b7e3-01088def8fc7", "dosage_form": "GEL", "pharm_class": ["Allergens [CS]", "Cell-mediated Immunity [PE]", "Increased Histamine Release [PE]", "Standardized Chemical Allergen [EPC]"], "product_ndc": "53045-140", "generic_name": "Benzocaine", "labeler_name": "Dharma Research, Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Avant", "active_ingredients": [{"name": "BENZOCAINE", "strength": "6.4 g/100g"}], "application_number": "M022", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20210122", "listing_expiration_date": "20261231"}